| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/26/2005 | US20050112761 making a synthetic cartilage patch by culturing said stromal cell in a differentiation medium to form a chondrocytic cell; introducing said cell to a biocompatible matrix capable of supporting chondrogenesis, culturing, cell secretes a cartilage-specific extracellular matrix component |
| 05/26/2005 | US20050112760 In vitro culture of tissue structures |
| 05/26/2005 | US20050112707 Method and compositions for inhibiting tumorigenesis |
| 05/26/2005 | US20050112208 Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation |
| 05/26/2005 | US20050112177 Gelled composition of whey protein and other beneficial constituents; shelf life; easy to use form |
| 05/26/2005 | US20050112176 Forming a gelled whey protein by processing a mixture of whey protein and other selected ingredients at an appropriate temperature and pH; bioavailable; packaged and easy to store and transport; shelf life |
| 05/26/2005 | US20050112147 Administering a neurotoxin |
| 05/26/2005 | US20050112146 Administering neurotoxin to infants; cerebral palsy therapy |
| 05/26/2005 | US20050112122 Generation of hematopoietic chimerism and induction of central tolerance |
| 05/26/2005 | US20050112112 Lactobacillus for treatment of eating disorders and pancreas defects; obesity; antidiabetic agents |
| 05/26/2005 | US20050112111 Microbiological culturein aqueous solution containing nutrients; probiotic activity |
| 05/26/2005 | US20050112109 Discovery, localization, harvest, and propagation of an FGF2 and BDNF-responsive population of neural and neuronal progenitor cells in the adult human forebrain |
| 05/26/2005 | US20050112107 Prevent adhesion of teeth; using argine, glycine, aspartic acid tripeptides |
| 05/26/2005 | US20050112105 Compositions and treatments for myelosuppression by ex vivo activated immune cells |
| 05/26/2005 | US20050112104 Forming cardiomyocytes in vivo using mesenchymal stem cells; cell differentiation |
| 05/26/2005 | US20050112103 Genetic engineered vectors encoding human low density lipoproteins ; control sequencing, gene expressionin heptacytes; anticholesterol agents; antilipemic agents |
| 05/26/2005 | US20050112097 Method for the treatment of cancer |
| 05/26/2005 | US20050112021 Reduction of Contaminants In Blood and Blood Products Using Photosensitizers and Peak Wavelengths of Light |
| 05/26/2005 | CA2545938A1 High-titer retroviral packaging cells |
| 05/26/2005 | CA2545718A1 Methods of using gelsolin to treat or prevent bacterial sepsis |
| 05/26/2005 | CA2545409A1 Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them |
| 05/26/2005 | CA2544816A1 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
| 05/26/2005 | CA2544726A1 Artificial tissue systems and uses thereof |
| 05/26/2005 | CA2544506A1 Use of strain of lactobacillus and byproducts thereof for inhibiting formation of blood vessels |
| 05/26/2005 | CA2544252A1 Stem cell culture medium and method of using said medium and the cells |
| 05/26/2005 | CA2541941A1 Anti-bacterial phage tail compositions and uses thereof |
| 05/25/2005 | EP1533369A1 Isolated phages and their use as disinfectant in food or for sanitation of factory environment |
| 05/25/2005 | EP1533366A1 Chitosan/acidic biopolymer hybrid fiber and culture base for animal cells |
| 05/25/2005 | EP1532254A2 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 05/25/2005 | EP1532253A1 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine |
| 05/25/2005 | EP1532161A2 Vectors for expression of hml-2 polypeptides |
| 05/25/2005 | EP1531870A1 Selected cell delivery for heart failure |
| 05/25/2005 | EP1531865A2 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 05/25/2005 | EP1531857A1 Metalloproteinase inhibitors |
| 05/25/2005 | EP1531841A1 Probiotics for gut neuromuscular functions |
| 05/25/2005 | EP1531840A1 Allomone repulsive and kairomone attractive compositions for controlling arachnids |
| 05/25/2005 | EP1531839A1 Avian appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 05/25/2005 | EP1531838A2 Stem cells for treating pancreatic damage |
| 05/25/2005 | EP1531803A1 Method of inhibiting prostate cancer cell proliferation |
| 05/25/2005 | EP1531676A2 Compositions and methods for liver growth and liver protection |
| 05/25/2005 | EP1497410A4 Cellular transplantation for heart regeneration |
| 05/25/2005 | EP1438390A4 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression |
| 05/25/2005 | EP1372670B1 Caloporoside derivatives, methods for the production thereof and their use |
| 05/25/2005 | EP1165106B1 Composition and method for inducing apoptosis in prostate cancer cells by m-dna and mcc |
| 05/25/2005 | EP1064281B1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents |
| 05/25/2005 | EP0813419B1 Modulators of regulatory proteins |
| 05/25/2005 | EP0688227B1 Production of human papillomavirus capsid protein and virus-like particles |
| 05/25/2005 | DE202005001718U1 Surgical floss useful for wound healing in humans and animals consists of extract of natural cowhide or other type of natural leather, e.g. sheepskin, goatskin and pigskin, treated with disinfectant and optionally high-molecular dextran |
| 05/25/2005 | CN1620500A Corona-virus-like particles comprising functionally deleted genomes |
| 05/25/2005 | CN1620498A Compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability |
| 05/25/2005 | CN1620467A Secreted protein |
| 05/25/2005 | CN1620310A Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| 05/25/2005 | CN1620303A Skin perparation for external use containing purpuricenus temminckii frass as the active ingredient |
| 05/25/2005 | CN1620255A Protein-containing foodstuff comprising a coss-linking enzyme and a hydrocolloid |
| 05/25/2005 | CN1620251A Cultured and encapsulated pancreatic stem cells |
| 05/25/2005 | CN1618457A Method for preparing prepn. of immune modulation factor |
| 05/25/2005 | CN1203183C Retroviral vectors comprising functional splice donor site and a functional splice acceptor site |
| 05/25/2005 | CN1203093C Method for producing whole silkworm powder milk-containing and ferritin |
| 05/25/2005 | CN1202860C Anti-SARS virus transfer factor preparation method |
| 05/25/2005 | CN1202859C Chinese medicine for treating protrasion of lumber intervertebral disci |
| 05/25/2005 | CN1202858C Medicine for psoriasis |
| 05/25/2005 | CN1202855C Traditional Chinese medicine for deafness and tinnitus and its preparation method |
| 05/25/2005 | CN1202849C Oral liquid for nephrosis |
| 05/25/2005 | CN1202843C Narcotic medical composition, preparing process and use thereof |
| 05/25/2005 | CN1202837C Application of sea horse in preparation of medicine and health care food for treating benign prostatauxe |
| 05/25/2005 | CN1202836C Toad skin preparation and productive process thereof |
| 05/25/2005 | CN1202748C Producing method for instant, full content and emulsion type frog fat product |
| 05/25/2005 | CN1202736C Method for administering viable microorganism composition for poultry |
| 05/25/2005 | CA2448831A1 Multi-stage cascade boosting vaccine |
| 05/24/2005 | US6897069 System and method for electroporating a sample |
| 05/24/2005 | US6897061 Into multipotent cells (neurons/astrocytes/oligodendrocytes) in vitro; stem cells; nerve/fibroblast growth factors; extracellular matrices |
| 05/24/2005 | US6897060 Composition comprising multipotent neural stem cells for generation of hematopoietic cells |
| 05/24/2005 | US6897054 For controlling in vitro cell proliferation; genetic engineering |
| 05/24/2005 | US6896910 Anti-fatigue and tonic agent containing wild ginseng |
| 05/24/2005 | US6896907 Use of bioactive fraction from cow urine distillate (‘go-mutra’) as a bio-enhancer of anti-infective, anti-cancer agents and nutrients |
| 05/24/2005 | US6896888 Comprises Bacillus Calmette-Guerin (BCG) formulated with keratolytic agent (salicyclic acid) for topical application |
| 05/24/2005 | US6896883 Biocontrol for plants with Bacillus subtilis, Pseudomonas putida, and Sporobolomyces roseus |
| 05/24/2005 | US6896882 Breaking peptidoglycans in cell wall; destroying genomes |
| 05/24/2005 | CA2170243C Novel therapeutic and dietetic uses of a brain phospholipid-based complex |
| 05/24/2005 | CA2157664C Process for obtaining ultra pure egg oil and its use |
| 05/24/2005 | CA2133316C In vitro generation of human dendritic cells and uses thereof |
| 05/20/2005 | CA2450297A1 Method for preventing mineralization in the periodontal ligament (pdl) |
| 05/19/2005 | WO2005045026A1 Insulin-expressing human islet cell lines capable of reversibly proliferating and use thereof |
| 05/19/2005 | WO2005045012A1 Endodermal stem cells in liver and methods for isolation thereof |
| 05/19/2005 | WO2005045009A1 Methods for isolating t cells and uses thereof |
| 05/19/2005 | WO2005045008A1 Method for inducing chondrogenesis on mesenchymal stem cells |
| 05/19/2005 | WO2005044844A2 Protozoan strains of reduced virulence and use thereof |
| 05/19/2005 | WO2005044299A1 Cytoprotective effects of ethyl pyruvate |
| 05/19/2005 | WO2005021575A3 Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties |
| 05/19/2005 | WO2004105701B1 Compositions and methods for symptomatic relief |
| 05/19/2005 | WO2004062626A3 Composition and method for treating age-related disorders |
| 05/19/2005 | WO2004022762A9 Orthopoxvirus vectors, genes and products thereof |
| 05/19/2005 | WO2004015125A9 Process for preparing peptides with anti-hypertensive properties |
| 05/19/2005 | US20050108785 Using nuclear transplantation as tool in generating transgenic cells for treatment and prevention of liver, nervous system, cardiovascular and bone disorders; regenerative medicine |
| 05/19/2005 | US20050108784 Expression vector comprising nucleotide sequences coding spinocerebellar ataxia-1 gene for use in treatment and prevention of nervous system disorders |
| 05/19/2005 | US20050107326 GENETIC ENGINEERED nucleic acid, VECTOR CODING ANTISENSE AGENTS; FOR USE IN KILLING PREFERENTIAL TARGET CELLS OR MICRORGANISMS; biodrugs as antitumor agent, bactericides, anticarcinogenic agent; target on antibiotic resistant bacteria, drug-resistant cancer cells |
| 05/19/2005 | US20050107323 Cardiac arrhythmia treatment methods |
| 05/19/2005 | US20050107314 Modulation of cd200 receptors |
| 05/19/2005 | US20050107256 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 05/19/2005 | US20050106724 Self renewing dental follicle tissues for use in generating periodontal ligament like membrane structures; tissue repair and regenerative medicine |